Health News

50-Year Trends in Smoking Related Deaths
Too many people have died from smoking-related illnesses in the past 50 years. But there is good news: quitting smoking starts the healing process and immediately begins to reduce the risks of smoking-related disease.
Speeding Up the Discovery Process
To find out if a lung cancer prevention drug is effective, scientists may follow thousands of patients for more than a decade. A recent discovery of a molecular response may significantly shorten these trials.
Cancer Screening Can Be a Life Saver
A key to beating lung cancer is finding it early on. After extensive research, the American Cancer Society now recommends CT screening for older patients with a history of smoking.
Beta Blockers Help Block Cancer Spread
Radiation is a common method to kill or shrink cancer cells. Lung cancer patients taking heart medication during radiotherapy may have better results than those not taking these drugs.
Vaccine for Late-Stage Cancer Fails
Vaccines are showing promise as medication therapy for patients with advanced-stage lung cancer. A new vaccine, however, recently failed to extend the lives of certain cancer patients.
New Gene Test IDs Patients for Cancer Drug
Targeted therapy can do wonders. The trick is finding which patients have the genetic mutation or some other alteration that drugs can effectively target.
Lung Cancer Check Advised for COPD Patients
A diagnosis of chronic obstructive pulmonary disease ( COPD ) often is the end result of a lifetime of smoking. So should  COPD patients want to get a checkup for lung cancer as well?
Chemo-Drug Combo Clobbers Cancer
Gene therapies to treat lung cancer are continuing to emerge. A new combination of drugs may help lung cancer patients live longer. Several gene mutations have been identified in lung cancer cells.
Targeted Cancer Therapy Casts Wider Net
Targeting cancer gene mutations has been changing the way non-small cell lung cancer ( NSCLC ) is treated. As scientists learn more about the genetic makeup of tumors, more personalized therapy has become available.
An Alternative When Cancer Grows
When non-small cell lung cancer ( NSCLC ) grows again after shrinking on targeted therapy, patients may turn to chemotherapy. Adding local therapy to targeted drugs could offer another solution.